Industry: Pharmaceuticals, Biotechnology
Agensys, Inc. is a privately held biotechnology company that is developing a pipeline of therapeutic monoclonal antibodies to treat solid tumor cancers. These antibodies, many of which are fully human, are being generated to a diverse portfolio of proprietary, clinically relevant cancer targets that encompass 14 types of solid tumors. The Company has the capabilities to generate, develop and manufacture antibody products and, through a partnership with Abgenix, has access to the XenoMouse® technologies required to generate fully human antibodies. The Company has also established clinical development capabilities which will move its antibody products forward into clinical ( www.agensys.com )
Agensys , Inc.
1545 17Th St.
Santa Monica, California 90404
USA
Tel: (310) 820-8029
Fax: (310) 820-8489
Instant Messenger: